RASAL2 and head and neck squamous cell carcinoma: Thus, in vivo studies demonstrated that the overexpression of RASAL2-AS1 promoted HNSCC cell proliferation and growth, while silencing METTL14 inhibited HNSCC cell proliferation and growth.